Want to join the conversation?
Oppenheimer analyst Anna Andreeva asks $ANF to talk about foreign tourism business in the US, either as percent of sales or percent of store footprint. CFO Joanne Crevoiserat says that in the 2H16, the company is focused on improvement and expects improvement based on investments being made in the marketing side.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?